Amgen

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Amgen 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About AMGN

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. 

CEO
Robert A. Bradway
CEORobert A. Bradway
Employees
31,500
Employees31,500
Headquarters
Thousand Oaks, California
HeadquartersThousand Oaks, California
Founded
1980
Founded1980
Employees
31,500
Employees31,500

AMGN Key Statistics

Market cap
178.04B
Market cap178.04B
Price-Earnings ratio
24.09
Price-Earnings ratio24.09
Dividend yield
2.79%
Dividend yield2.79%
Average volume
2.55M
Average volume2.55M
High today
$346.25
High today$346.25
Low today
$324.63
Low today$324.63
Open price
$332.64
Open price$332.64
Volume
3.82M
Volume3.82M
52 Week high
$391.29
52 Week high$391.29
52 Week low
$261.43
52 Week low$261.43

Stock Snapshot

The current Amgen(AMGN) stock price is $329.57, with a market capitalization of 178.04B. The stock trades at a price-to-earnings (P/E) ratio of 24.09 and offers a dividend yield of 2.8%.

On 2026-05-02, Amgen(AMGN) stock traded between a low of $324.63 and a high of $346.25. Shares are currently priced at $329.57, which is +1.5% above the low and -4.8% below the high.

The Amgen(AMGN)'s current trading volume is 3.82M, compared to an average daily volume of 2.55M.

During the past year, Amgen(AMGN) stock moved between $261.43 at its lowest and $391.29 at its peak.

During the past year, Amgen(AMGN) stock moved between $261.43 at its lowest and $391.29 at its peak.

AMGN News

TipRanks 9h
Amgen Earnings Call Highlights Growth Engines, Tax Risk

Amgen Inc ((AMGN)) has held its Q1 earnings call. Read on for the main highlights of the call. Claim 55% Off TipRanks Unlock hedge fund-level data and powerful...

Nasdaq 16h
Why the S&P 500 and Nasdaq Hit Record Highs While the Dow Fell Today

Key Points The S&P 500 and Nasdaq 100 hit fresh records Friday morning; the Dow turned negative by midday. Apple's 4.5% post-earnings jump is carrying the tec...

Why the S&P 500 and Nasdaq Hit Record Highs While the Dow Fell Today
TipRanks 19h
Amgen Price Target Raised to $425 as Strong Execution and Expanding Pipeline Underpin Maintained Buy Rating

Goldman Sachs analyst Salveen Richter maintained a Buy rating on Amgen today and set a price target of $425.00. Unlock hedge fund-level data and powerful inves...

Analyst ratings

51%

of 37 ratings
Buy
40.5%
Hold
51.4%
Sell
8.1%

More AMGN News

Nasdaq 19h
Nasdaq 100 Movers: AMGN, DDOG

In early trading on Friday, shares of Datadog topped the list of the day's best performing components of the Nasdaq 100 index, trading up 5.1%. Year to date, Da...

Nasdaq 100 Movers: AMGN, DDOG
Nasdaq 19h
Dow Movers: AMGN, AAPL

In early trading on Wednesday, shares of Apple topped the list of the day's best performing Dow Jones Industrial Average components, trading up 0.6%. Year to da...

Dow Movers: AMGN, AAPL
TipRanks 19h
Amgen price target raised to $307 from $304 at BofA

BofA raised the firm’s price target on Amgen (AMGN) to $307 from $304 and keeps an Underperform rating on the shares. The firm, which adjusted estimates in-line...

The Motley Fool 1d
Amgen Q1 2026 Earnings Transcript

Image source: The Motley Fool. Thursday, April 30, 2026 at 4:30 p.m. ET Call participants Chairman & Chief Executive Officer — Robert A. Bradway Executive Vice...

Amgen Q1 2026 Earnings Transcript
The Wall Street Journal 2d
Amgen Posts Higher First-Quarter Profit, Revenue

Amgen’s product sales were up 4%, led by 9% growth in product volume. Clodagh Kilcoyne / Reuters Amgen AMGN 2.43 %increase; green up pointing triangle said its...

Amgen Posts Higher First-Quarter Profit, Revenue
TipRanks 2d
Amgen sees FY26 CapEx $2.6B; share repurchases not to exceed $3B

16:03 EDT Amgen (AMGN) sees FY26 CapEx $2.6B; share repurchases not to exceed $3B Published first on TheFly – the ultimate source for real-time, market-moving...

Investor's Business Daily 2d
Amgen's Numbers Are Out: It Gets To Keep Its Cholesterol Crown — For Now

Technology Amgen's Numbers Are Out: It Gets To Keep Its Cholesterol Crown — For Now Licensing Amgen (AMGN) widely beat the Street's first-quarter expectations l...

Amgen's Numbers Are Out: It Gets To Keep Its Cholesterol Crown — For Now

People also own

Based on the portfolios of people who own AMGN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.